Emerging Growth Equities, Ltd. Initiates Coverage of CombiMatrix Corporation with a BUY Rating and an $18.00 Price Target
KING OF PRUSSIA, Pa., Aug. 18 /PRNewswire/ -- Emerging Growth Equities, Ltd. initiates coverage of CombiMatrix Corporation (NASDAQ:CBMX) with a BUY rating and an $18.00 price target. CombiMatrix is a life sciences company focused on developing and commercializing in vitro genetic diagnostics that leverage its core... More...>>

01/31/2008

6:00AM

PRNUS

CombiMatrix and Clarient Collaborate to Market, Sell Novel Genomics-Based Test for Chronic Lymphotic Leukemia (CLL)
The HemeScan(TM) Test Provides Prognostic Marker Precision and Simultaneous Diagnostic Monitoring MUKILTEO, Wash. and ALISO VIEJO, Calif., Jan. 31 /PRNewswire-FirstCall/ -- CombiMatrix Corporation (NASDAQ:CBMX) and Clarient, Inc. (NASDAQ:CLRT) today jointly announced establishment of a strategic partnership to market... More...>>

LSE and PLUS quotes are live. NYSE and AMEX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions :: Contact Us :: Request an Exchange :: Affiliate Scheme
Copyright1999-2009 ADVFN PLC. Copyright and limited reproduction :: Privacy Policy :: Investment Warning :: Advertise with us :: Data accreditations :: Investor Relations :: Press office :: Jobs

ADDITIONAL SERVICES AVAILABLE FROM ADVFN
					ADVFN Forex Channel Exchange Rates, FX Prices Charts, Forex Brokers & Currency Conversion

33 site:2us nasdaq cbmx091108 08:14 Stock Message Boards ( 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 )